Targeting Wild-Type and Mutationally Activated FGFR4 in Rhabdomyosarcoma with the Inhibitor Ponatinib (AP24534).
Saved in:
| Title: | Targeting Wild-Type and Mutationally Activated FGFR4 in Rhabdomyosarcoma with the Inhibitor Ponatinib (AP24534). |
|---|---|
| Authors: | Li, Samuel Q.1, Cheuk, Adam T.1, Shern, Jack F.1, Song, Young K.1, Hurd, Laura1, Liao, Hongling1, Wei, Jun S.1, Khan, Javed1 khanjav@mail.nih.gov |
| Source: | PLoS ONE. Oct2013, Vol. 8 Issue 10, p1-9. 9p. |
| Database: | Academic Search Ultimate |
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0076551 |
